Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06222476
NA

Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.

Sponsor: Yan Bi

View on ClinicalTrials.gov

Summary

The main purpose of this study is to explore the improvement of renal function before and after the intervention of dorzagliatin in patients with type 2 diabetes.

Official title: A Multicentric, Prospective, Randomized Study Evaluating the Improvement of Renal Function Outcomes With Dorzagliatin in Patients With Type 2 Diabetes Mellitus With Early Kidney Injury.

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

106

Start Date

2024-02-20

Completion Date

2026-06-30

Last Updated

2024-01-24

Healthy Volunteers

No

Interventions

DRUG

Dorzagliatin

Dorzagliatin will be initiated and maintained at 75mg twice a day

DRUG

Gliclazide

Gliclazide will be initiated and maintained at 30mg once a day

Locations (1)

Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University

Nanjing, Jiangsu, China